Serum uric acid and prehypertension among Chinese adults

Journal of Hypertension

Volumn 27, Issue 9, 2009, Pages 1761-1765

  Liang, Jun ^a   Xue, Ying ^a   Zou, Caiyan ^a   Zhang, Tong ^a   Song, Huaidong ^b   Qi, Lu ^c  

^a XUZHOU CENTRAL HOSPITAL   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Age; Fasting glucose; Prehypertension; Uric acid

Indexed keywords

GLUCOSE; LIPID; URIC ACID;

ADULT; AGE; ARTICLE; CHINA; CHINESE; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBESITY; PREHYPERTENSION; PRIORITY JOURNAL; URIC ACID BLOOD LEVEL;

EID: 73249149688     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32832e0b44     Document Type: Article

References (34)

1. Wang Y, Wang QJ. The prevalence of prehypertension and hypertension among us adults according to the new joint national committee guidelines: new challenges of the old problem. Arch Intern Med 2004; 164:2126-2134. (Pubitemid 39410802)
2. Elliott WJ, Black HR. Prehypertension. Nat Clin Pract Cardiovasc Med 2007; 4:538-548.
3. Hsia J, Margolis KL, Eaton CB, Wenger NK, Allison M, Wu L, et al. Prehypertension and cardiovascular disease risk in the women's health initiative. Circulation 2007; 115:855-860. (Pubitemid 46294726)
4. Zhang Y, Galloway JM, Welly TK, Wiebers DO, Whisnant JP, Devereux RB, et al. Incidence and risk factors for stroke in American Indians: the strong heart study. Circulation 2008; 118:1577-1584.
5. Sironi AM, Pingitore A, Ghione S, De Marchi D, Scattini B, Positano V, et al. Early hypertension is associated with reduced regional cardiac function, insulin resistance, epicardial, and visceral fat Hypertension 2008; 51:282-288. (Pubitemid 351159940)
6. Matsuura H. Prehypertension and metabolic syndrome: prevention of hypertension and cardiovascular events. Hypertens Res 2008; 31:1275-1276.
7. Onat A, Yazici M, Can G, Kaya Z, Bulur S, Hergenc G. Predictive value of prehypertension for metabolic syndrome, diabetes, and coronary heart disease among Turks. Am J Hypertens 2008; 21:890-895.
8. Zhang Y, Lee ET, Devereux RB, Yeh J, Best LG, Fabsitz RR, Howard BV. Prehypertension, diabetes, and cardiovascular disease risk in a populationbased sample: the strong heart study. Hypertension 2006; 47:410-414. (Pubitemid 43740283)
9. Selby JV, Friedman GD, Guesenberry CP Jr. Precursors of essential hypertension: pulmonary function, heart rate, uric acid, serum cholesterol, and other serum chemistries. Am J Epidemiol 1990; 131:1017-1027.
10. Hunt SC, Stephenson SH, Hopkins PN, Williams RR. Predictors of an increased risk of future hypertension in Utah. A screening analysis. Hypertension 1991; 17:969-976.
11. Krishnan E, Kwoh CK, Schumacher HR, Kuller L Hyperuricemia and incidence of hypertension among men without metabolic syndrome. Hypertension 2007; 49:298-303. (Pubitemid 46143005)
12. Mellen PB, Bleyer AJ, Erlinger TP, Evans GW, Nieto FJ, Wagenknecht LE, et al. Serum une acid predicts incident hypertension in a biethnic cohort: the atherosclerosis risk in communities study. Hypertension 2006; 48:1037-1042.
13. Sundstrom J, Sullivan L, D'Agostino RB, Levy D, Kannel WB, Vasan RS. Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence. Hypertension 2005; 45:28-33. (Pubitemid 40066409)
14. Feig Dl, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med 2008; 359:1811-1821.
15. Syamala S, Li J, Shankar A. Association between serum uric acid and prehypertension among us adulte. J Hypertens 2007; 25:1583-1589. (Pubitemid 47056563)
16. Sarafidis PA, Nilsson PM. The metabolic syndrome: a glance at its history. J Hypertens 2006; 24:621-626.
17. Forman JP, Choi H, Curhan GC. Plasma uric acid level and risk for incident hypertension among men. J Am Soc Nephrol 2007; 18:287-292. (Pubitemid 46053441)
18. Dunieman S, Simon R. Flexible regression models with cubic splines. Stat Med 1989; 8:551-561. (Pubitemid 19116001)
19. Johnson RJ, Feig Dl, Herrera-Acosta J, Kang DH. Resurrection of uric acid as a causal risk factor in essential hypertension. Hypertension 2005; 45:18-20. (Pubitemid 40066407)
20. Mazzali M, Hughes J, Kim YG, Jefferson JA, Kang DH, Gordon KL, et al. Elevated uric acid increases blood pressure in the rat by a novel crystalindependent mechanism. Hypertension 2001 ; 38:1101-1106. (Pubitemid 34252813)
21. Lu Z, Dong B, Wu H, Chen T, Zhang Y, Wu J, Xiao H. Serum uric acid level in primary hypertension among Chinese nonagenarians/centenarians. J Hum Hypertens 2009; 23:113-121.
22. Taniguchi Y, Hayashi T, Tsumura K, Endo G, Fujii S, Okada K. Serum uric acid and the risk for hypertension and type 2 diabetes in Japanese men: the Osaka health survey. J Hypertens 2001 ; 19:1209-1215. (Pubitemid 32595276)
23. Brand FN, McGee DL, Kannel WB, Stokes J 3rd, Castelli WP. Hyperuricemia as a risk factor of coronary heart disease: the Framingham study. Am J Epidemiol 1985; 121:11-18.
24. Kang DH, Nakagawa T, Feng L, Watenabe S, Han L, Mazzali M, et al. A role for uric acid in lhe progression of renal disease. J Am Soc Nephrol 2002; 13:2888-2897. (Pubitemid 35386908)
25. Mazzali M, Kanellis J, Han L, Feng L, Xia YY, Chen Q, et al. Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressureindependent mechanism. Am J Physiol Renal Physiol 2002; 282:F991 F997.
26. Khosla UM, Zharikov S, Finch JL, Nakagawa T, Roncal C, Mu W, et al. Hyperuricemia induces endothelial dysfunction. Kidney Int 2005; 67:1739-1742.
27. Rao GN, Corson MA, Berk BC. Uric acid stimulates vascular smooth muscle cell proliferation by increasing platelet-derived growth factor achain expression. J Biol Chem 1991 ; 266:8604-8608.
28. Feig DI, Nakagawa T, Karumanchi SA, Oliver WJ, Kang DH, Finch J, Johnson RJ. Hypothesis: uric acid, nephron number, and the pathogenesis of essential hypertension. Kidney Int 2004; 66:281-287. (Pubitemid 38870104)
29. Corry DB, Eslami P, Yamamoto K, Nyby MD, Makino H, Tuck ML Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system. J Hypertens 2008; 26:269-275.
30. Baylis C, Schmidt R The aging glomerulus. Semin Nephrol 1996; 16:265-276.
31. Fuiano G, Sund S, Mazza G, Rosa M, Caglioti A, Gallo G, et al. Renal hemodynamic response to maximal vasodilating stimulus in healthy older subjects. Kidney Int 2001 ; 59:1052-1058. (Pubitemid 32206867)
32. Chemey DZ, Sochett EB, Miller JA. Gender differences in renal responses to hyperglycemia and angiotensin-converting enzyme inhibition in diabetes. Kidney Int 2005; 68:1722-1728.
33. Lansang MC, Osei SY, Coletti C, Krupinski J, Hollenberg NK. Hyperglycaemia-induced intrarenal ras activation: the contribution of metabolic pathways. J Renin Angiotensin Aldosterone Syst 2002; 3:19-23. (Pubitemid 34467697)
34. Manning PJ, Sutherland WH, Walker RJ, de Jong SA, Berry EA. The effect of glucose ingestion on inflammation and oxidative stress in obese individuals. Metabolism 2008; 57:1345-1349.